These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
989 related articles for article (PubMed ID: 23324188)
21. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096 [TBL] [Abstract][Full Text] [Related]
22. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases]. Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380 [TBL] [Abstract][Full Text] [Related]
23. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour. Satoh T; Aoki Y; Kasamatsu T; Ochiai K; Takano M; Watanabe Y; Kikkawa F; Takeshima N; Hatae M; Yokota H; Saito T; Yaegashi N; Kobayashi H; Baba T; Kodama S; Saito T; Sakuragi N; Sumi T; Kamura T; Yoshikawa H Eur J Cancer; 2015 Feb; 51(3):340-51. PubMed ID: 25559616 [TBL] [Abstract][Full Text] [Related]
24. Current management of malignant germ cell tumor of the ovary. Aziz MF Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():262-76. PubMed ID: 7661594 [TBL] [Abstract][Full Text] [Related]
25. The significance of comprehensive staging surgery in malignant ovarian germ cell tumors. Liu Q; Ding X; Yang J; Cao D; Shen K; Lang J; Zhang G; Xin X; Xie X; Wu Y Gynecol Oncol; 2013 Dec; 131(3):551-4. PubMed ID: 24007946 [TBL] [Abstract][Full Text] [Related]
26. Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience. Peiretti M; Zanagnolo V; Aletti GD; Bocciolone L; Colombo N; Landoni F; Minig L; Biffi R; Radice D; Maggioni A Gynecol Oncol; 2010 Nov; 119(2):259-64. PubMed ID: 20800269 [TBL] [Abstract][Full Text] [Related]
27. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S; J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344 [TBL] [Abstract][Full Text] [Related]
28. Prognostic factors and survival of borderline ovarian tumors in Rajavithi Hospital between 1979-2006 A.D. Sornsukolrat S; Tuipae S J Med Assoc Thai; 2012 Sep; 95(9):1141-8. PubMed ID: 23140030 [TBL] [Abstract][Full Text] [Related]
29. [Treatment of malignant ovarian germ cell tumors with relapse or failed in primary therapy]. Yang JX; Wang HB; Shen K; Huang HF; Pan LY; Wu M Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):273-6. PubMed ID: 19570465 [TBL] [Abstract][Full Text] [Related]
30. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy. Juretzka MM; Barakat RR; Chi DS; Iasonos A; Dupont J; Abu-Rustum NR; Poynor EA; Aghajanian C; Spriggs D; Hensley ML; Sabbatini P Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584 [TBL] [Abstract][Full Text] [Related]
31. The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy. Kapp KS; Kapp DS; Poschauko J; Stücklschweiger GF; Hackl A; Pickel H; Petru E; Winter R Gynecol Oncol; 1999 Sep; 74(3):400-7. PubMed ID: 10479500 [TBL] [Abstract][Full Text] [Related]
32. [Clinical analysis of 15 cases of malignant ovarian germ cell tumors with lung metastasis]. Liu Y; Ren T; Feng FZ; Wan XR; Shen K; Xiang Y Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):40-4. PubMed ID: 22455692 [TBL] [Abstract][Full Text] [Related]
33. Cytoreductive surgery for stage IV epithelial ovarian cancer. Zang RY; Zhang ZY; Cai SM; Li ZT; Chen J; Tang MQ; Liu Q J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968 [TBL] [Abstract][Full Text] [Related]
34. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy]. Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176 [TBL] [Abstract][Full Text] [Related]
35. Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy. Yoo SC; Kim WY; Yoon JH; Chang SJ; Chang KH; Ryu HS Acta Obstet Gynecol Scand; 2010; 89(1):126-30. PubMed ID: 19878051 [TBL] [Abstract][Full Text] [Related]
36. Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy. Bolis G; Villa A; Guarnerio P; Ferraris C; Gavoni N; Giardina G; Melpignano M; Scarfone G; Zanaboni F; Parazzini F Cancer; 1996 Jan; 77(1):128-31. PubMed ID: 8630918 [TBL] [Abstract][Full Text] [Related]
37. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576 [TBL] [Abstract][Full Text] [Related]
38. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution. Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930 [TBL] [Abstract][Full Text] [Related]
39. Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study. Saygili U; Guclu S; Uslu T; Erten O; Ture S; Demir N J Surg Oncol; 2002 Nov; 81(3):132-7. PubMed ID: 12407725 [TBL] [Abstract][Full Text] [Related]
40. Postoperative nodal status and diffuse-type histology are independent prognostic factors in resectable advanced gastric carcinomas after preoperative chemotherapy. Koh YW; Park YS; Ryu MH; Ryoo BY; Park HJ; Yook JH; Kim BS; Kang YK Am J Surg Pathol; 2013 Jul; 37(7):1022-9. PubMed ID: 23715160 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]